Hepatitis C virus inhibitors

Details for Australian Patent Application No. 2008350327 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Langley, David R.; Goodrich, Jason; Deon, Daniel H.; Meanwell, Nicholas A.; Martel, Alain; Romine, Jeffrey Lee; Ruediger, Edward H.; Good, Andrew C.; Lavoie, Rico; Lopez, Omar D.; St. Laurent, Denis R.; Bachand, Carol; Belema, Makonen; Hamann, Lawrence G.; Wang, Gan; Snyder, Lawrence B.; James, Clint A.; Yang, Fukang; Nguyen, Van N.

Agent A J Park

Pub. Number AU-A-2008350327

PCT Pub. Number WO2009/102318

Filing date 12 February 2008

Wipo publication date 20 August 2009

International Classifications

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 31/22 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/102318 Priority application(s): WO2009/102318

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008350334-Imidazolyl biphenyl imidazoles as hepatitis C virus inhibitors

2008350323-Process for manufacturing medium and high molecular weight polyesters